Receptor nature and ligand requirements
Unlike membrane targets, intracellular receptors are soluble proteins. They are localized directly inside the cell — in its cytosol or within the nucleus. This location dictates strict requirements for substances (agonists) capable of interacting with them.
To reach its target, the ligand must independently overcome the plasma membrane. This is only possible for lipophilic substances. Classic examples of such compounds include:
- Steroid hormones (including glucocorticoids and sex hormones).
- Thyroid hormones.
- Fat-soluble vitamins (group A, or retinoids, and group D).
Genomic effect: activation sequence
The mechanism of action of substances via nuclear receptors is implemented at the genetic level and represents a complex multistep process. The entire sequence from molecule penetration to altered cell functions is called the genomic effect.
The process includes the following stages:
- The lipophilic ligand penetrates unhindered into the cell.
- In the cytosol, the substance finds its specific receptor and binds to it.
- A conformational change occurs in the structure of the receptor itself.
- The resulting drug-receptor complex is translocated (transported) into the cell nucleus.
- In the nucleus, the complex binds to strictly defined regions of the DNA molecule.
The result of this interaction is a change in gene transcription. The transcription process can be either activated or repressed (suppressed). In turn, this entails an increase or decrease in the synthesis of functionally active proteins, such as enzymes or cytokines. It is the shift in the pool of cellular proteins that triggers a new biochemical cascade, which we observe as the pharmacological effect of the drug.
Temporal characteristics of the response
A crucial pharmacological feature of drugs acting via intracellular receptors is the slow onset of effects.
Unlike ion channels, where the response occurs in milliseconds, here there is a significant latent (hidden) period. It can range from several hours to a whole day. This delay is due to the fact that the cell objectively requires time to execute the genetic program: initiation of transcription, translation, and subsequent synthesis of a sufficient number of new protein molecules.
Implementation examples: glucocorticoids and PPARs
The easiest way to understand the essence of intracellular receptors is through the classic model of glucocorticoids. These drugs produce two characteristic effects by altering gene expression:
- Metabolic effect (hyperglycemia). The hormone-receptor complex activates genes responsible for gluconeogenesis enzymes. As a result, glucose synthesis is stimulated, and its blood level rises.
- Anti-inflammatory and immunosuppressive effects. The drug causes repression (inhibition) of genes encoding various pro-inflammatory agents. The production of adhesion molecules, cytokines, and the cyclooxygenase enzyme is reduced.
Another important target in this group is PPARs (peroxisome proliferator-activated receptors). They play a key role in regulating the body's lipid metabolism. In clinical practice, PPARs serve as the site of action for lipid-lowering agents (for example, the drug clofibrate).
Remembering the main ligand groups is helped by the mnemonic: S — Steroids, VI — Vitamins (A and D), TER — Thyroid hormones, PETI — PPARs.
Class and exam questions
Why do the effects of intracellular receptors develop slowly?
The action requires altering gene transcription at the DNA level. A latent period from several hours to a day is spent on the synthesis of new functionally active proteins in the cell.
What chemical properties are mandatory for the ligands of these receptors?
Ligands must be lipophilic. Only lipophilicity allows molecules to freely pass through the plasma membrane to receptors located in the cytosol or nucleus.
Through what mechanism do glucocorticoids exert an anti-inflammatory effect?
They bind to intracellular receptors and cause the repression of certain genes. This leads to a decrease in the synthesis of pro-inflammatory agents: cytokines, adhesion molecules, and cyclooxygenase.
What are PPARs?
These are intracellular receptors activated by peroxisome proliferators. They regulate lipid metabolism and serve as a target for lipid-lowering drugs (e.g., clofibrate).
What else to study on this topic
- Conformational changes of the receptor upon ligand binding
- The process of substance-receptor complex translocation into the nucleus
- Mechanism of activation of gluconeogenesis enzymes
- Repression of cyclooxygenase and cytokine genes
- PPARs and the mechanism of action of clofibrate
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Intracellular receptors" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in "General Pharmacology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.